Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Johnson & Johnson (JNJ)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
Dow 30 Stock Roundup: Boeing Bags Big Orders at Paris Air Show; Wal-Mart to Buy Bonobos

The Dow experienced a turbulent week, even as the broader market was guided by the fortunes of tech stocks.

DD : 80.99 (-0.43%)
UAL : 76.79 (-0.85%)
AAPL : 146.28 (+0.45%)
CELG : 134.31 (+0.47%)
VZ : 45.39 (-0.07%)
CVX : 105.00 (+0.53%)
JNJ : 136.43 (+0.28%)
DOW : 63.47 (-0.56%)
PFE : 34.17 (+0.32%)
S : 8.05 (-0.25%)
T : 37.95 (-0.39%)
XOM : 81.61 (+0.65%)
FB : 155.07 (+1.09%)
AMZN : 1,003.74 (+0.24%)
BA : 202.23 (+1.40%)
WMT : 74.84 (-0.90%)
WFM : 42.94 (-0.60%)
Healthcare ETF (IYH) Hits New 52-Week High

This healthcare ETF hit a new 52-week high. Are more gains in store for this ETF?

JNJ : 136.43 (+0.28%)
IYH : 169.33 (-0.12%)
CLVS : 95.00 (-1.84%)
Healthcare ETF (IYH) Hits New 52-Week High

This healthcare ETF hit a new 52-week high. Are more gains in store for this ETF?

JNJ : 136.43 (+0.28%)
IYH : 169.33 (-0.12%)
CLVS : 95.00 (-1.84%)
High School Student from Kansas Receives Top Honor at International BioGENEius Challenge

Erin Smith (11th Grade, Kansas) was named the grand prize winner of the International BioGENEius Challenge, the premier competition for high school students that recognizes outstanding ...

JNJ : 136.43 (+0.28%)
Markets Right Now: US stock indexes drift to a mixed close

The latest on developments in financial markets (All times local):

JNJ : 136.43 (+0.28%)
UNH : 185.25 (-0.67%)
Watch for Johnson&Johnson to Potentially Pullback After Gaining 1.06% Yesterday

Johnson&Johnson (NYSE:JNJ) traded in a range yesterday that spanned from a low of $135.27 to a high of $137.00. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of...

JNJ : 136.43 (+0.28%)
Watch for Johnson&Johnson to Potentially Pullback After Gaining 1.06% Yesterday

Johnson&Johnson (NYSE:JNJ) traded in a range yesterday that spanned from a low of $135.27 to a high of $137.00. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of...

JNJ : 136.43 (+0.28%)
Global Diagnostic Catheters Market to Grow at a CAGR of 7.3% by 2023 - Increase in Number of Diagnostic & Imaging Centers

Research and Markets has announced the addition of the "Global Diagnostic Catheters Market Insights, Opportunity, Analysis, Market Shares And Forecast 2017 - 2023" report to their offering. The global...

EW : 120.15 (+1.37%)
SIEGY : 69.8900 (+0.30%)
ABT : 49.08 (-0.39%)
SYK : 141.12 (-0.07%)
TRMB : 36.45 (-0.30%)
BSX : 28.10 (+0.86%)
TRUMF : 40.1300 (+1.61%)
JNJ : 136.43 (+0.28%)
STJ : 80.82 (+0.16%)
CAH : 79.68 (+1.18%)
MDT : 89.20 (+0.12%)
Global Chronic Kidney Disease (CKD) Drugs Market to Reach $17.4 Billion by 2025 - Analysis By Drug Class & Geography

Research and Markets has announced the addition of the "Global Chronic Kidney Disease (CKD) Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive...

KSPHF : 27.4271 (unch)
KERX : 6.75 (+5.63%)
JNJ : 136.43 (+0.28%)
AGN : 246.46 (-0.26%)
TEVA : 32.61 (+0.28%)
AMGN : 172.50 (-0.76%)
PFE : 34.17 (+0.32%)
Here's Why Geron (GERN) is a Good Stock to Invest in Now

Geron Corporation (GERN) is developing anti-cancer therapies based on telomerase inhibitors.

VVUS : 1.22 (+5.17%)
JNJ : 136.43 (+0.28%)
GERN : 2.94 (unch)
REGN : 517.33 (-1.75%)
Erythropoietin (EPO) Drugs Market Forecast to 2025 - Analysis By Drug Class (Biologics, Biosimilars), Product (Epoetin-alfa, Epoetin-beta, Darbepoetin-alfa, Others), Application & Segment

Research and Markets has announced the addition of the "Erythropoietin (EPO) Drugs Market Analysis By Drug Class (Biologics, Biosimilars), By Product (Epoetin-alfa, Epoetin-beta, Darbepoetin-alfa, Others),...

JNJ : 136.43 (+0.28%)
TEVA : 32.61 (+0.28%)
AMGN : 172.50 (-0.76%)
Johnson & Johnson Releases 2016 Health for Humanity Report

Johnson & Johnson has released its 2016 Health for Humanity Report sharing progress on environmental, social and governance measures, which advance the Company's mission to profoundly improve the course...

JNJ : 136.43 (+0.28%)
Global Markets for Allergy Diagnostics and Treatments - Expected to Increase from Nearly $40.0 Billion in 2016 to $52.7 Billion in 2021

Research and Markets has announced the addition of the "Global Markets for Allergy Diagnostics and Treatments" report to their offering. This report is designed to provide a comprehensive look at the...

BMRA : 2.50 (+2.46%)
ALR : 50.17 (-0.12%)
JNJ : 136.43 (+0.28%)
AGN : 246.46 (-0.26%)
LH : 151.62 (+0.85%)
Global Corrective Contact Lenses Market 2017-2021 with Cooper, Johnson & Johnson, Novartis & Valeant Pharmaceuticals Dominating - Research and Markets

Research and Markets has announced the addition of the "Global Corrective Contact Lenses Market 2017-2021" report to their offering.

JNJ : 136.43 (+0.28%)
NVS : 86.34 (unch)
Fitch Sees Fastest Global Growth in 10 Years: ETFs To Buy

Credit rating agency Fitch expects the global growth to reach 2.9% in 2017 and 3.1% in 2018.

MSFT : 71.21 (+1.35%)
GOOGL : 986.09 (+0.97%)
AAPL : 146.28 (+0.45%)
JNJ : 136.43 (+0.28%)
IOO : 84.63 (+0.09%)
ACWI : 65.54 (+0.17%)
AMZN : 1,003.74 (+0.24%)
VT : 68.07 (+0.18%)
Shire's (SHPG) ADHD Drug Mydayis Receives Approval in US

Shire Plc (SHPG) announced that the FDA has approved its new attention deficit hyperactivity disorder (ADHD) drug, Mydayis (mixed salts of a single-entity amphetamine product) in patients 13 years and...

VVUS : 1.22 (+5.17%)
JNJ : 136.43 (+0.28%)
SHPG : 172.98 (-1.11%)
PFE : 34.17 (+0.32%)
Global Corrective Contact Lenses Market 2017-2021 with Cooper, Johnson & Johnson, Novartis & Valeant Pharmaceuticals Dominating

Research and Markets has announced the addition of the "Global Corrective Contact Lenses Market 2017-2021" report to their offering. The report forecasts that the global corrective contact lenses market...

JNJ : 136.43 (+0.28%)
NVS : 86.34 (unch)
S&P 500 Buybacks Fall 17.5% Year-over-Year to $133.1 Billion for Q1 2017

S&P Dow Jones Indices ("S&P DJI") today announced preliminary results indicating that S&P 500® stock buybacks, or share repurchases, totaled $133.1 billion for Q1 2017. This is a 1.6% decrease from the...

CVS : 77.41 (+0.25%)
HUM : 238.42 (+0.60%)
AAPL : 146.28 (+0.45%)
C : 63.41 (-0.33%)
BAC : 22.82 (-0.48%)
JPM : 86.86 (-0.18%)
JNJ : 136.43 (+0.28%)
PFE : 34.17 (+0.32%)
BMY : 56.64 (-1.20%)
DIS : 104.36 (+0.13%)
AET : 152.10 (-0.58%)
MSFT : 71.21 (+1.35%)
WFC : 52.45 (-0.08%)
V : 95.58 (+1.73%)
PG : 89.42 (+0.44%)
SPGI : 146.70 (+0.91%)
ISRG : 948.94 (-0.55%)
GE : 27.57 (+0.07%)
AIG : 63.02 (-0.05%)
BA : 202.23 (+1.40%)
WMT : 74.84 (-0.90%)
Zacks.com featured highlights: Johnson & Johnson, NantKwest, Delek US Holdings, Abbot Labs and Winnebago

Zacks.com featured highlights: Johnson & Johnson, NantKwest, Delek US Holdings, Abbot Labs and Winnebago

ABT : 49.08 (-0.39%)
JNJ : 136.43 (+0.28%)
DK : 25.76 (+1.70%)
NK : 7.49 (+7.46%)
WGO : 34.40 (+1.47%)
Fitch Sees Fastest Global Growth in 10 Years: ETFs To Buy

Credit rating agency Fitch expects the global growth to reach 2.9% in 2017 and 3.1% in 2018.

MSFT : 71.21 (+1.35%)
GOOGL : 986.09 (+0.97%)
AAPL : 146.28 (+0.45%)
JNJ : 136.43 (+0.28%)
IOO : 84.63 (+0.09%)
ACWI : 65.54 (+0.17%)
AMZN : 1,003.74 (+0.24%)
VT : 68.07 (+0.18%)

Van Meerten Stock Picks

5 Great Growth Stocks
Each week Value Line publishes a list of growth stocks the for the past 10 years have had a 10% increase in Sales, Cash Flow, Earnings, Dividends and Book Value and are expected to continue that 10% growth for the next 5 years.
NVDA -4.54 , CGNX +1.13 , EDU +0.07 , LUV +0.40 , ZBRA +0.17
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

Barchart Morning Call

OVERNIGHT MARKETS AND NEWS Sep E-mini S&Ps ( ESU17 unch) this morning are down -0.75 of a point ( -0.03% ). Losses were limited as bank stocks moved higher with Bank of America and Morgan Stanley both up almost 1% in pre-market trading... Read More

Chart of the Day

Arista Networks (ANET) is the Barchart Chart of the Day.  The cloud solutions company has a Trend Spotter buy signal, a Weighted Alpha of 152.23+ and gained 118.87% in the last year.
Read More

Brugler Ag Report

Today's Commentary

Corn futures ended the week with losses of 3 1/4 to 5 1/2 cents, with July down 6.84% since last Friday. Friday’s Commitment of traders report showed spec funds adding back 35,896 contracts to their net short position as of Tuesday, after last ...
Read More

Alan Brugler writes this daily agricultural markets overview with opening, midday and closing comments directed at the gain and meat Ag markets.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.